Down Syndrome – Waisman Center – UW–Madison

Genome-wide association of tau neuroimaging and plasma biomarkers in adults with Down syndrome

Single-nucleus analysis reveals oxidative stress in Down syndrome basal forebrain neurons at birth

Molecular and cellular processes disrupted in the early postnatal Down syndrome prefrontal cortex

Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex

Eye Tracking as a Tool for Detecting Alzheimer’s Disease in People With Down Syndrome

Single-nucleus analysis reveals dysregulated oxidative phosphorylation in Down syndrome basal forebrain at birth

Timeline to symptomatic Alzheimer’s disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort study

The effects of mosaicism on biological and clinical markers of Alzheimer’s disease in adults with Down syndrome

Consequences of trisomy 21 for brain development in Down syndrome

The complexity of opportunities to respond used by mothers and fathers of children with Down syndrome: A preliminary investigation